About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1153 record(s)
Req # A-2017-001135
All items submitted in the process of obtaining the Drug Identificatoin Number (DIN) - Homeopathic Medicine (HM) for DIN-HM 80022460.Organization: Health Canada
October 2023
Req # A-2018-000655
All scientific studies used and/or referenced by Pest Management Regulatory Agency (PMRA) in determining the proposed re-evaluation decision PRVD2018-13 for Strychnine and its Associated End-use Products (Ground Squirrel Use) dated 29 June 2018.Organization: Health Canada
October 2023
Req # A-2018-001105
Documents constituting the "STATUS DECISION OF CONTROLLED AND NON-CONTROLLED SUBSTANCE(S)" also known as the "Health Canada status decision" issued from January 1, 2012 to November 5, 2018.Organization: Health Canada
October 2023
Req # A-2019-000334
Dymista (Drug Identification Number (DIN) 02432889): - Module 1 submission for Notifiable Changes (NC) for Control Number: 202447 - Module 1 submission for NC for Control Number: 214083.Organization: Health Canada
October 2023
Req # A-2020-000017
In relation to the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017, please provide any Notices of Deficiency (NOD); Notices of Non-Compliance (NON); NOD-Withdrawal or NON-Withdrawal .Organization: Health Canada
October 2023
Req # A-2020-000082
Records containing information whether Health Canada has concluded its review of the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017.Organization: Health Canada
October 2023
Req # A-2020-000181
The following briefing notes: "Consumer and clinical radiation bureau,radiofrequency fields and safety code 6," prepared in September 2019 for the Federation of Canadian Municipalities.Organization: Health Canada
October 2023
Req # A-2020-000186
all records regarding Palantir Technologies, Palantir Canada, or David MacNaughton from February 1, 2020 to April 30, 2020.Organization: Health Canada
October 2023
Req # A-2020-000371
All briefing notes and related materials given to Minister Hajdu related to the coronavirus, Covid 19 in March.Organization: Health Canada
October 2023
Req # A-2020-001367
Any documents indicating what cycle threshold (Ct) value is currently being used when analysing Polymerase Chain Reaction (PCR) tests (for SARS CoV-2) to determine whether the specimen is positive.Organization: Health Canada
October 2023